期刊文献+

运用介入化疗加栓塞治疗晚期宫颈癌的疗效与预后分析

Efficacy and prognosis of patients with advanced cervical cancer treated with interventional therapy and chemotherapy
原文传递
导出
摘要 目的对应用介入化疗加栓塞治疗晚期宫颈癌的疗效与预后质量进行探讨分析。方法选择62例晚期宫颈癌患者的临床资料。结果11例CR,42例PR,6例SD,3例PD,总治疗有效率为85.5%;共发生45例骨髓抑制,患者主要出现恶心、呕吐等消化道反应。结论应用介.,k4g疗加栓塞治疗晚期宫颈癌患者,能够显著提高近期临床疗效,大大降低手术治疗风险。 OBJECTIVE To investigate and analyze the therapeutic effect and prognosis of advanced cervical cancer patients treated with interventional therapy and chemotherapy. METHODS The clinical data of 62 patients with advanced cervical cancer were selected. RESULTS Eleven cases of CR~ 42 PR, 6 SD, 3 PD~ the total effective rate was 85.5~, 45 cases of bone marrow suppression, the main symptoms are nausea, vomiting and other gastrointestinal reactions. CONCLUSION The application of interventional therapy and chemotherapy in the treatment o{ advanced cervical cancer patients, can significantly improve the short-term clinical curative effect, greatly reduce the risk of surgical treatment.
作者 李杨
出处 《中华肿瘤防治杂志》 CAS 北大核心 2015年第B22期231-232,共2页 Chinese Journal of Cancer Prevention and Treatment
关键词 晚期宫颈癌 介入治疗 化疗方案 疗效 预后 advanced cervical cancer interventional therapy chemotherapy prognosis prognosis
  • 相关文献

参考文献5

二级参考文献37

  • 1贺能树,吴恩惠.中华影像医学介入放射学卷[M].北京:人民卫生出版社2005.405-421.
  • 2Kaneyasu Y, Nagai N, Nagata Y, et al. Intra-arterial intusion chemotherapy using cisplatin with radiotherapy for stage Ⅲ squamous cell carcinoma of the cervix [J]. Int J Radiat Oncol Biol Phys,2009,75 ( 2 ) : 369 - 377.
  • 3Chen H,Liang C ,Zhang L,et al. Clincial efficacy of modified preoperative neoauvant chemotherapy in the treatment of locally ad- vanced (stage Ⅰ b2 to ⅡB ) cervical cancer: randomized study [J]. Gyneeol Oncol,2008,110 ( 3 ) : 308 - 315.
  • 4Antonio GM, Lucia GC, Natalia C, et al. The current role of neoadjuvant chemotherapy in the management of cervical carcinoma [J]. Gynecol Oncol,2008,110 (3 Suppl 2) :36 - 40.
  • 5Blumenschein GR Jr, Kabbinavar F, Menon H, et al. A phase Ⅱ, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer[J]. Ann Oncol, 2011,22 (9) :2057 - 2067.
  • 6Miller K, Wang M, Gralow J, et al. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer[ J ]. N Engl J Med,2007,357 ( 26 ) : 2666 - 2676.
  • 7Kawase S, Okuda T, Ikeda M, et al. Intraarterial cisplatin/nedaplatin and ntravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer[ J ]. Gynecol Oncol,2006,102 ( 3 ) :493 - 499.
  • 8王卫,陈春林,刘萍.宫颈癌动脉灌注栓塞化疗中新鲜明胶海绵颗粒药物缓释作用的评估[D].南京医科大学,2009.
  • 9Chao YH,Kim DY,Kim JH,et al. Comparative study of neoadju- vant chemotherapy before radical hysterectomy and radical surger y alone in stage I b2 ]I a bulky cervical cancer[J. J Gynecol On- col,2009,20(1) 22-27.
  • 10Kumar JV, Doval DC, Rao R, et al. A retrospegtive study of pa- tients with locally advanced cancer of cervix treated with neoadju- vant chemotherapy followed by radical surgery[J. Int J Gynecol Cancer,2009,19(3) :417-422.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部